FI955524A - Kiinteinä liuoksina olevia valmisteita - Google Patents

Kiinteinä liuoksina olevia valmisteita Download PDF

Info

Publication number
FI955524A
FI955524A FI955524A FI955524A FI955524A FI 955524 A FI955524 A FI 955524A FI 955524 A FI955524 A FI 955524A FI 955524 A FI955524 A FI 955524A FI 955524 A FI955524 A FI 955524A
Authority
FI
Finland
Prior art keywords
pct
solid solutions
date nov
preparations
sec
Prior art date
Application number
FI955524A
Other languages
English (en)
Swedish (sv)
Other versions
FI955524A0 (fi
Inventor
Sven Grabowski
Winfried Mueller
Joerg Rosenberg
Rudolf Binder
Axel Sanner
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI955524A publication Critical patent/FI955524A/fi
Publication of FI955524A0 publication Critical patent/FI955524A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cephalosporin Compounds (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI955524A 1993-05-18 1995-11-16 Kiinteinä liuoksina olevia valmisteita FI955524A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4316537A DE4316537A1 (de) 1993-05-18 1993-05-18 Zubereitungen in Form fester Lösungen
PCT/EP1994/001489 WO1994026267A1 (de) 1993-05-18 1994-05-09 Zubereitungen in form fester lösungen

Publications (2)

Publication Number Publication Date
FI955524A true FI955524A (fi) 1995-11-16
FI955524A0 FI955524A0 (fi) 1995-11-16

Family

ID=6488330

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955524A FI955524A0 (fi) 1993-05-18 1995-11-16 Kiinteinä liuoksina olevia valmisteita

Country Status (23)

Country Link
US (1) US5684040A (fi)
EP (1) EP0697867B1 (fi)
JP (1) JPH08510219A (fi)
KR (1) KR960702305A (fi)
CN (1) CN1123524A (fi)
AT (1) ATE209913T1 (fi)
AU (1) AU688328B2 (fi)
BR (1) BR9406414A (fi)
CA (1) CA2163255A1 (fi)
CZ (1) CZ300895A3 (fi)
DE (2) DE4316537A1 (fi)
DK (1) DK0697867T3 (fi)
ES (1) ES2169073T3 (fi)
FI (1) FI955524A0 (fi)
HR (1) HRP940305A2 (fi)
HU (1) HUT73657A (fi)
IL (1) IL109532A (fi)
NO (1) NO954660L (fi)
NZ (1) NZ267080A (fi)
PL (1) PL311698A1 (fi)
SI (1) SI9420035A (fi)
WO (1) WO1994026267A1 (fi)
ZA (1) ZA943368B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
WO2002024168A1 (fr) * 2000-09-25 2002-03-28 Nippon Shinyaku Co., Ltd. Procede de production d'une dispersion solide medicinale
BR0210518A (pt) 2001-06-22 2004-06-22 Pfizer Prod Inc Composições farmacêuticas de dispersões de drogas e polìmeros neutros
CA2450762A1 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers
JP2004534811A (ja) * 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク ポリマーと薬剤の集合体を含む医薬組成物
WO2003034302A1 (fr) * 2001-10-15 2003-04-24 Stark Co., Ltd. Serveur de fourniture de contenu et systeme de fourniture de contenu dote d'un tel serveur
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
BR0307332A (pt) 2002-02-01 2004-12-07 Pfizer Prod Inc Formas de dosagem farmacêuticas de liberação controlada de um inibidor da proteìna de transferência do éster de colesterol
RU2005103625A (ru) 2002-08-12 2005-08-20 Пфайзер Продактс Инк. (Us) Фармацевтические композиции полуупорядоченных лекарств и полимеров
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
WO2005005400A1 (ja) * 2003-07-11 2005-01-20 Osaka Industrial Promotion Organization スルホン酸エステル化合物およびそれを用いた蛍光プローブ
WO2005005401A1 (ja) * 2003-07-11 2005-01-20 Osaka Industrial Promotion Organization スルホン酸エステル化合物およびそれを用いた蛍光プローブ
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS5446837A (en) * 1977-09-19 1979-04-13 Kanebo Ltd Easily absorbable nifedipin composition, its preparation, and anti-stenocardia containing the same
BE880713A (fr) * 1978-12-21 1980-06-19 Sandoz Sa Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
DE3243158A1 (de) * 1982-11-23 1984-05-24 Basf Ag, 6700 Ludwigshafen Neue sulfonsaeureester von hydroxycumarinen, ihre herstellung und sie enthaltende arzneimittel
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンa物質含有易溶性固形製剤
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
JP2636265B2 (ja) * 1987-10-06 1997-07-30 萬有製薬株式会社 脳循環改善剤
DE3830355A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur herstellung von pharmazeutischen tabletten
DE3834860A1 (de) * 1988-10-13 1990-04-19 Basf Ag Heterocyclisch substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel

Also Published As

Publication number Publication date
KR960702305A (ko) 1996-04-27
CA2163255A1 (en) 1994-11-24
ZA943368B (en) 1995-11-17
HUT73657A (en) 1996-09-30
NO954660D0 (no) 1995-11-17
CZ300895A3 (en) 1996-02-14
DE59409994D1 (de) 2002-01-17
ATE209913T1 (de) 2001-12-15
US5684040A (en) 1997-11-04
AU688328B2 (en) 1998-03-12
HRP940305A2 (en) 1996-12-31
JPH08510219A (ja) 1996-10-29
DE4316537A1 (de) 1994-11-24
IL109532A (en) 1997-11-20
DK0697867T3 (da) 2002-03-11
HU9503296D0 (en) 1996-01-29
EP0697867A1 (de) 1996-02-28
NO954660L (no) 1995-11-17
ES2169073T3 (es) 2002-07-01
PL311698A1 (en) 1996-03-04
CN1123524A (zh) 1996-05-29
IL109532A0 (en) 1994-08-26
WO1994026267A1 (de) 1994-11-24
SI9420035A (en) 1996-06-30
NZ267080A (en) 1996-11-26
FI955524A0 (fi) 1995-11-16
EP0697867B1 (de) 2001-12-05
AU6926394A (en) 1994-12-12
BR9406414A (pt) 1995-12-19

Similar Documents

Publication Publication Date Title
FI955524A (fi) Kiinteinä liuoksina olevia valmisteita
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
TR199801179T2 (xx) Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
KR910007538A (ko) α-아밀라아제 활성저해제
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
MY104634A (en) 1-<[o-(cyclopropylcarbony)phenyl]>- 3-(4,6-dimethoxy-2-pyrimidinyl) urea and method for the preparation thereof.
FI852995L (fi) Stabila salter av polyanioner innehaollande s-adenosyl-l-methionin (sam).
CA2247848A1 (en) Nitric oxide donors capable of reducing toxicity from drugs
ES2101860T3 (es) Percarbonato de sodio encapsulado, estable al almacenamiento, y procedimiento para su preparacion.
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
ZA909124B (en) Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms
IT1224405B (it) Composti attivi sul sistema cardiovascolare
NO980058L (no) Opthalmiske preparater
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
IE870845L (en) N'-substituted-n,n'-diacylhydrazines
AU6878900A (en) 1,4-dihydropyridine-5-carboxylic acid ester derivatives and method for the preparation thereof
TR199800958A2 (xx) Herbisidal 3,5-Difloropridinleri.
GR970100096A (el) Εξωτερικη διαταξη κατα των παρασιτων για βοοειδη με βαση τη ν-φαινυλπυραζολη, ειδικα σκουλαρικια.
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
EP0462291A4 (en) Acat enzyme inhibiting composition
AU3138489A (en) Peptides with pharmaceutical activity
ATE252598T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
ATE154599T1 (de) 1-alpha-cyclopropyl-alpha-(substituierte oxy)-o- tolyl sulfamoyl-3-(4,6-dimethoxy-2- pyrimidinyl)harnstoffe als herbizide wirkstoffe
KR950005303A (ko) 진균 감염 치료 방법(method of treating fungal infections)